BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 16567005)

  • 21. [Sensitivity and specificity of 4 domestic ELISA kits for detection of hepatitis B virus markers].
    Wu X; Zhou C; Huang WJ; Qi ZB; Liang ZL; Li HM; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Sep; 29(9):915-8. PubMed ID: 19173858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An improved Abbott ARCHITECT assay for the detection of hepatitis B virus surface antigen (HBsAg).
    Lou SC; Pearce SK; Lukaszewska TX; Taylor RE; Williams GT; Leary TP
    J Clin Virol; 2011 May; 51(1):59-63. PubMed ID: 21367654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact.
    Weber B
    J Clin Virol; 2005 Feb; 32(2):102-12. PubMed ID: 15653412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus transfusion risk in China: proficiency testing for the detection of hepatitis B surface antigen.
    Zhang R; Wang L; Li J
    Transfus Med; 2010 Oct; 20(5):322-8. PubMed ID: 20409073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants.
    Mühlbacher A; Weber B; Bürgisser P; Eiras A; Cabrera J; Louisirirotchanakul S; Tiller FW; Kim HS; v Helden J; Bossi V; Echevarria JM
    Med Microbiol Immunol; 2008 Mar; 197(1):55-64. PubMed ID: 17899185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved detection of hepatitis B virus surface antigen by a new rapid automated assay.
    Weber B; Bayer A; Kirch P; Schlüter V; Schlieper D; Melchior W
    J Clin Microbiol; 1999 Aug; 37(8):2639-47. PubMed ID: 10405414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.
    Lukhwareni A; Burnett RJ; Selabe SG; Mzileni MO; Mphahlele MJ
    J Med Virol; 2009 Mar; 81(3):406-12. PubMed ID: 19152393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests.
    Schmidt M; Nübling CM; Scheiblauer H; Chudy M; Walch LA; Seifried E; Roth WK; Hourfar MK
    Vox Sang; 2006 Oct; 91(3):237-43. PubMed ID: 16958836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
    Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; van Drimmelen H; David B; Lelie N; De Micco P
    Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory.
    Taylor P; Pickard G; Gammie A; Atkins M
    J Clin Virol; 2004 Apr; 30 Suppl 1():S11-5. PubMed ID: 15062762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of an indigenously manufactured rapid immunochromatographic test for detection of HBsAg.
    Raj AA; Subramaniam T; Raghuraman S; Abraham P
    Indian J Pathol Microbiol; 2001 Oct; 44(4):413-4. PubMed ID: 12035352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. European collaborative evaluation of the Enzygnost HBsAg 6.0 assay: performance on hepatitis B virus surface antigen variants.
    Avellón A; Echevarría JM; Weber B; Weik M; Schobel U; Willems WR; Gerlich WH
    J Med Virol; 2011 Jan; 83(1):95-100. PubMed ID: 21108344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detecting hepatitis B virus large surface protein to filtrate the occult HBV infection].
    Wu ZL; Zhuang P; Lin HL; Lu XD; Liu J; Zhong XQ; Lin GC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):381-3. PubMed ID: 20387493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European performance evaluations of the ADVIA Centaur infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnostics.
    Dati F; Denoyel G; van Helden J
    J Clin Virol; 2004 Apr; 30 Suppl 1():S6-10. PubMed ID: 15062761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Simultaneous detection of hepatitis B virus surface antigen (HBsAg) and hepatitis C virus (HCV) related antibodies by an immunochromatographic test method using synthesized oligonucleotide-bound protein probes, OligoFast].
    Ohshiro M; Yamane N; Shibahara Y; Oka M; Uesaka Y
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2002; 13(1):7-13. PubMed ID: 12542392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do we need an 'in-house' neutralization assay for confirmation of hepatitis B surface antigen? Answers from a tertiary care hospital in India.
    Fletcher GJ; Gnanamony M; David J; Ismail AM; Subramani T; Abraham P
    J Gastroenterol Hepatol; 2010 May; 25(5):942-5. PubMed ID: 19929924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variable capacity of 13 hepatitis B virus surface antigen assays for the detection of HBsAg mutants in blood samples.
    Servant-Delmas A; Mercier-Darty M; Ly TD; Wind F; Alloui C; Sureau C; Laperche S
    J Clin Virol; 2012 Apr; 53(4):338-45. PubMed ID: 22296790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study about seroconversion of HBV NAT screening-positive crowd from blood donors].
    Wang DW; Wang TB; Liu FP; Shi LL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):127-9. PubMed ID: 18574536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene.
    Koyanagi T; Nakamuta M; Sakai H; Sugimoto R; Enjoji M; Koto K; Iwamoto H; Kumazawa T; Mukaide M; Nawata H
    Med Sci Monit; 2000; 6(6):1165-9. PubMed ID: 11208474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.